5-151505749-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_001447.3(FAT2):c.12866G>A(p.Cys4289Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,613,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001447.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAT2 | NM_001447.3 | c.12866G>A | p.Cys4289Tyr | missense_variant | 24/24 | ENST00000261800.6 | NP_001438.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAT2 | ENST00000261800.6 | c.12866G>A | p.Cys4289Tyr | missense_variant | 24/24 | 1 | NM_001447.3 | ENSP00000261800.5 | ||
FAT2 | ENST00000520200.5 | c.3182G>A | p.Cys1061Tyr | missense_variant | 11/11 | 1 | ENSP00000429678.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000997 AC: 25AN: 250768Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135750
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461476Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727078
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.12866G>A (p.C4289Y) alteration is located in exon 23 (coding exon 23) of the FAT2 gene. This alteration results from a G to A substitution at nucleotide position 12866, causing the cysteine (C) at amino acid position 4289 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at